These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 7591288

  • 21. Progression in MCF-7 breast cancer cell tumorigenicity: compared effect of FGF-3 and FGF-4.
    Hajitou A, Deroanne C, Noël A, Collette J, Nusgens B, Foidart JM, Calberg-Bacq CM.
    Breast Cancer Res Treat; 2000 Mar; 60(1):15-28. PubMed ID: 10845805
    [Abstract] [Full Text] [Related]

  • 22. Autocrine transformation by fibroblast growth factor 9 (FGF-9) and its possible participation in human oncogenesis.
    Matsumoto-Yoshitomi S, Habashita J, Nomura C, Kuroshima K, Kurokawa T.
    Int J Cancer; 1997 May 02; 71(3):442-50. PubMed ID: 9139882
    [Abstract] [Full Text] [Related]

  • 23. Transformation and amplification of the K-fgf proto-oncogene in NIH-3T3 cells, and induction of metastatic potential.
    Damen JE, Greenberg AH, Wright JA.
    Biochim Biophys Acta; 1991 Sep 23; 1097(2):103-10. PubMed ID: 1911883
    [Abstract] [Full Text] [Related]

  • 24. The K-fgf/hst oncogene induces transformation through an autocrine mechanism that requires extracellular stimulation of the mitogenic pathway.
    Talarico D, Basilico C.
    Mol Cell Biol; 1991 Feb 23; 11(2):1138-45. PubMed ID: 1990270
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Preferential activation of Fgf8 by proviral insertion in mammary tumors of Wnt1 transgenic mice.
    Kapoun AM, Shackleford GM.
    Oncogene; 1997 Jun 19; 14(24):2985-9. PubMed ID: 9205106
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. MMTV-induced mammary tumorigenesis: gene discovery, progression to malignancy and cellular pathways.
    Callahan R, Smith GH.
    Oncogene; 2000 Feb 21; 19(8):992-1001. PubMed ID: 10713682
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Hyperplasia and impaired involution in the mammary gland of transgenic mice expressing human FGF4.
    Morini M, Astigiano S, Mora M, Ricotta C, Ferrari N, Mantero S, Levi G, Rossini M, Barbieri O.
    Oncogene; 2000 Dec 07; 19(52):6007-14. PubMed ID: 11146552
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Differential transforming abilities of non-secreted and secreted forms of human fibroblast growth factor-1.
    Forough R, Xi Z, MacPhee M, Friedman S, Engleka KA, Sayers T, Wiltrout RH, Maciag T.
    J Biol Chem; 1993 Feb 05; 268(4):2960-8. PubMed ID: 7679105
    [Abstract] [Full Text] [Related]

  • 36. Fibroblast growth factor 4 transfection of MCF-7 cells produces cell lines that are tumorigenic and metastatic in ovariectomized or tamoxifen-treated athymic nude mice.
    McLeskey SW, Kurebayashi J, Honig SF, Zwiebel J, Lippman ME, Dickson RB, Kern FG.
    Cancer Res; 1993 May 01; 53(9):2168-77. PubMed ID: 8481920
    [Abstract] [Full Text] [Related]

  • 37. Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells.
    Salomon DS, Perroteau I, Kidwell WR, Tam J, Derynck R.
    J Cell Physiol; 1987 Mar 01; 130(3):397-409. PubMed ID: 3494020
    [Abstract] [Full Text] [Related]

  • 38. Identification of a novel human fibroblast growth factor and characterization of its role in oncogenesis.
    Jeffers M, Shimkets R, Prayaga S, Boldog F, Yang M, Burgess C, Fernandes E, Rittman B, Shimkets J, LaRochelle WJ, Lichenstein HS.
    Cancer Res; 2001 Apr 01; 61(7):3131-8. PubMed ID: 11306498
    [Abstract] [Full Text] [Related]

  • 39. Rbpj conditional knockout reveals distinct functions of Notch4/Int3 in mammary gland development and tumorigenesis.
    Raafat A, Lawson S, Bargo S, Klauzinska M, Strizzi L, Goldhar AS, Buono K, Salomon D, Vonderhaar BK, Callahan R.
    Oncogene; 2009 Jan 15; 28(2):219-30. PubMed ID: 18836481
    [Abstract] [Full Text] [Related]

  • 40. Fgf10 is an oncogene activated by MMTV insertional mutagenesis in mouse mammary tumors and overexpressed in a subset of human breast carcinomas.
    Theodorou V, Boer M, Weigelt B, Jonkers J, van der Valk M, Hilkens J.
    Oncogene; 2004 Aug 12; 23(36):6047-55. PubMed ID: 15208658
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.